Page 1

Albertsons Companies Albertsons Companies , Inc. Reports Second Quarter Fiscal 2021 Results Boise , ID - October 18 , 2021 Raises Fiscal 2021 Outlook Announces 20 % Increase to Quarterly Dividend Albertsons Companies , Inc. ( NYSE : ACI ) ( the " Company " ) today reported results for the second quarter of fiscal 2021 , which ended September 11 , 2021 . Second Quarter of Fiscal 2021 Highlights Identical sales increased 1.5 % ; on a two - year stacked basis identical sales growth was 15.3 % Digital sales increased 5 % ; on a two - year stacked basis digital sales growth was 248 % Net income per Class A common share of $ 0.52 Adjusted net income per Class A common share of $ 0.64 Net income of $ 295 million ; Adjusted net income of $ 370 million Adjusted EBITDA of $ 965 million Increased quarterly common stock dividend by 20 % to $ 0.12 per share " We are pleased with our second quarter results as we continue to execute our transformation strategy . The favorable consumer backdrop together with our focus on in - store excellence , accelerating our digital and omni - channel capabilities , increasing productivity and strengthening our talent and culture , are driving increased identical sales and improved performance , " said Vivek Sankaran , CEO . " Based on this strong performance , today we announced a 20 % increase to our quarterly dividend , and have raised our fiscal year 2021 outlook . " Second Quarter of Fiscal 2021 Results Compared to Second Quarter of Fiscal 2020 Sales and other revenue was $ 16.5 billion during the 12 weeks ended September 11 , 2021 ( " second quarter of fiscal 2021 " ) compared to $ 15.8 billion during the 12 weeks ended September 12 , 2020 ( " second quarter of fiscal 2020 " ) . The increase was primarily driven by the Company's 1.5 % increase in identical sales and higher fuel sales . Gross profit margin decreased to 28.6 % during the second quarter of fiscal 2021 compared to 29.0 % during the second quarter of fiscal 2020. Excluding the impact of fuel , gross profit margin was flat compared to the second quarter of fiscal 2020 primarily due to higher product , supply chain and advertising costs , offset by benefits related to productivity initiatives , favorable product mix and improved pharmacy margins related to administering COVID - 19 vaccines .